NCT01137240

Brief Summary

Hypothesis: Many patients with underlying mitochondrial disorders have feeding problems because of poor gastrointestinal motility; feeding problems lead to growth impairment and many affected children are malnourished.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

June 2, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 4, 2010

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

February 27, 2012

Status Verified

February 1, 2012

Enrollment Period

9 months

First QC Date

June 2, 2010

Last Update Submit

February 24, 2012

Conditions

Keywords

subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study

Study Arms (1)

Children with mitochondrial disorders

suffering from gastrointestinal dysfunction

Procedure: gastric emptying scan

Interventions

subjects will eat a solid meal (scrambled eggs, etc) or drink liquid (water or juice) mixed with approximately 0.5 millicuries of radioactive material. A scanner/external gamma camera will be placed over the subject's stomach at 15 minute intervals for a duration of 90 minutes (monitoring the amount of radioactivity in the stomach). As the radioactively-labeled food empties from the stomach, the amount of radioactivity in the stomach decreases. The rate at which the radioactivity leaves the stomach reflects the rate at which food is emptying from the stomach. The radioisotope has a half life of approximately. 6 hours and is totally eliminated from the body within 24 hours. In subjects with gastroparesis, the food and the attached radioactive material remain in the stomach longer than normal (usually hours) before emptying into the small intestine. As a result, the scanner continues to show radioactivity in the area of the stomach for hours after the test meal.

Children with mitochondrial disorders

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

children suffering form mitochondrial disorders.

You may qualify if:

  • Parents/Guardians are informed and given written consent.
  • Subject is willing and able to comply with all trial requirements
  • Subject is over 3 years of age.
  • Subject has a diagnosis of mitochondrial disorder validated by the modified Walker criteria used for diagnosis of mitochondrial diseases(9).
  • A female subject in the age group of 11 yrs. or older is not pregnant as evidenced by a negative urine dipstick pregnancy test
  • Subject to be enrolled has one or more of the following gastrointestinal signs and symptoms pertaining to gastrointestinal dysfunction like but not limited to abdominal pain, nausea, vomiting, bloating, indigestion, abdominal distention or sense of abdominal fullness.

You may not qualify if:

  • Subject is currently having one or more gastrointestinal disease/disorder that is not explained by the current knowledge of mitochondrial diseases. For example, patients suffering from peptic ulcer disease or inflammatory bowel diseases will be excluded.
  • Subject is a pregnant or a nursing female.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas- Houston Health Sceince Center

Houston, Texas, 77030, United States

Location

Related Publications (3)

  • Koenig MK. Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol. 2008 May;38(5):305-13. doi: 10.1016/j.pediatrneurol.2007.12.001.

    PMID: 18410845BACKGROUND
  • Gillis LA, Sokol RJ. Gastrointestinal manifestations of mitochondrial disease. Gastroenterol Clin North Am. 2003 Sep;32(3):789-817, v. doi: 10.1016/s0889-8553(03)00052-9.

    PMID: 14562575BACKGROUND
  • Nissenkorn A, Zeharia A, Lev D, Fatal-Valevski A, Barash V, Gutman A, Harel S, Lerman-Sagie T. Multiple presentation of mitochondrial disorders. Arch Dis Child. 1999 Sep;81(3):209-14. doi: 10.1136/adc.81.3.209.

    PMID: 10451392BACKGROUND

MeSH Terms

Conditions

Mitochondrial Diseases

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Jatinder Bhardwaj, MD

    Privat Practice - Toledo, OH

    PRINCIPAL INVESTIGATOR
  • Mary K Koenig, MD

    The University of Texas Medical School at Houston

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor - Pediatrics

Study Record Dates

First Submitted

June 2, 2010

First Posted

June 4, 2010

Study Start

June 1, 2010

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

February 27, 2012

Record last verified: 2012-02

Locations